VRTX Sentiment Analysis
We collect and analyze sentiment surrounding VRTX stock to help you make informed investment decisions.
VERTEX PHARMACEUTICALS INCORPORATED Hits Price Target Forecast with 16.48% Profit
Published on December 19, 2024
VERTEX PHARMACEUTICALS INCORPORATED (VRTX) has successfully reached the price target forecast set by QuantWave on December 19, 2024. The forecast signal date was October 22, 2024, with the stock trading at 474.91 $. The predicted direction was short,...
QuantWave Achieves 17.27% Profit Target for VERTEX PHARMACEUTICALS INCORPORATED
Published on July 30, 2024
QuantWave, the automated forecasting platform, has successfully hit its price target forecast for VERTEX PHARMACEUTICALS INCORPORATED, resulting in a profitable return of 17.27%. The forecast signal was initiated on May 14, 2024, at a price of 428.59...
VERTEX PHARMACEUTICALS INCORPORATED Hits Price Target Forecast with 19.2% Profit
Published on July 10, 2024
On March 12, 2024, QuantWave, an automated forecasting platform, issued a long signal for VERTEX PHARMACEUTICALS INCORPORATED with a price target forecast of $491.62. Fast forward to July 10, 2024, and the stock has indeed reached the predicted targ...
VERTEX PHARMACEUTICALS INCORPORATED Hits Price Target Forecast with 14.09% Profit
Published on July 10, 2024
On February 27, 2024, QuantWave, an automated forecasting platform, issued a long signal for VERTEX PHARMACEUTICALS INCORPORATED when the stock was trading at $430.92. The platform accurately predicted the price movement, and on July 10, 2024, the st...
VERTEX PHARMACEUTICALS Stock Hits Forecasted Price Target with 14.32% Profit: QuantWave Analysis
Published on June 4, 2024
VERTEX PHARMACEUTICALS INCORPORATED has successfully reached the price target forecasted by QuantWave, resulting in a profitable outcome for investors. The forecast signal date of March 5, 2024, indicated a long position with a price of $415.44. On J...
Vertex Pharmaceuticals Incorporated Hits Price Target Forecast with 9.92% Profit
Published on August 9, 2022
Vertex Pharmaceuticals Incorporated (VRTX) has successfully achieved the price target forecast set by QuantWave, resulting in a profit of 9.92%. The forecast, which signaled a long position on June 7, 2022, at a price of 271.86 USD, saw its target pr...